These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 23153407

  • 41. Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
    Jürgens T, Jafari M, Kreutzfeldt M, Bahn E, Brück W, Kerschensteiner M, Merkler D.
    Brain; 2016 Jan; 139(Pt 1):39-46. PubMed ID: 26667278
    [Abstract] [Full Text] [Related]

  • 42. Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability.
    Lansley J, Mataix-Cols D, Grau M, Radua J, Sastre-Garriga J.
    Neurosci Biobehav Rev; 2013 Jun; 37(5):819-30. PubMed ID: 23518268
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Association between pathological and MRI findings in multiple sclerosis.
    Filippi M, Rocca MA, Barkhof F, Brück W, Chen JT, Comi G, DeLuca G, De Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, Popescu BF, Lassmann H, Attendees of the Correlation between Pathological MRI findings in MS workshop.
    Lancet Neurol; 2012 Apr; 11(4):349-60. PubMed ID: 22441196
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Meningeal and cortical grey matter pathology in multiple sclerosis.
    Popescu BF, Lucchinetti CF.
    BMC Neurol; 2012 Mar 07; 12():11. PubMed ID: 22397318
    [Abstract] [Full Text] [Related]

  • 48. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
    Ciccarelli O, Barkhof F, Bodini B, De Stefano N, Golay X, Nicolay K, Pelletier D, Pouwels PJ, Smith SA, Wheeler-Kingshott CA, Stankoff B, Yousry T, Miller DH.
    Lancet Neurol; 2014 Aug 07; 13(8):807-22. PubMed ID: 25008549
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies.
    Sormani MP, Calabrese M, Signori A, Giorgio A, Gallo P, De Stefano N.
    PLoS One; 2011 Aug 07; 6(10):e26712. PubMed ID: 22028937
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Cortical morphology predicts placebo response in multiple sclerosis.
    Cherkasova MV, Fu JF, Jarrett M, Johnson P, Abel S, Tam R, Rauscher A, Sossi V, Kolind S, Li DKB, Sadovnick AD, Machan L, Girard JM, Emond F, Vosoughi R, Traboulsee A, Stoessl AJ.
    Sci Rep; 2022 Jan 14; 12(1):732. PubMed ID: 35031632
    [Abstract] [Full Text] [Related]

  • 54. Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis.
    van Wageningen TA, Gerrits E, Brouwer N, Brevé JJP, Geurts JJG, Eggen BJL, Boddeke HWGME, van Dam AM.
    Brain Commun; 2022 Jan 14; 4(2):fcac005. PubMed ID: 35282162
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Commentary: research highlights: Inflammation, demyelination and neurodegeneration: risky buddies in multiple sclerosis.
    Amadio S, Volonte C.
    CNS Neurol Disord Drug Targets; 2014 Feb 14; 13(1):4-5. PubMed ID: 24059312
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.